Massachusetts Institute of Technology
Sign in | Create Account

Dr. Tyler Jacks - Designing the Future of Cancer Research at MIT - MIT Club of Northern California

Dr. Tyler Jacks is director of the David H. Koch Institute for Integrative Cancer Research. He received his A.B. in biology from Harvard College and in 1988 his Ph.D. in Biochemistry and Biophysics from the University of California, San Francisco. After graduate work with Harold Varmus, Dr. Jacks was a postdoctoral fellow with Robert Weinberg at the Whitehead Institute. Dr. Jacks is David H. Koch Professor of Biology and an Investigator of the Howard Hughes Medical Institute. His lab has pioneered the use of gene-targeting technology in transgenic mice to study cancer-associated genes and construct mouse models of human cancers of the lung, brain and ovary. Dr. Jacks was named the 2005 Simon M. Shubitz Lecturer and Award recipient, and shared the 2005 Paul Marks Prize for Cancer Research awarded by Memorial Sloan-Kettering Cancer Center.

The David H. Koch Institute for Integrative Cancer Research is an out growth of the MIT Center for Cancer Research. The Center for Cancer Research initially established in 1973 has for over 30 years brought together extraordinary biologists in collaborative studies of human cancer. Over the past decade many of these researchers have established collaborations with other scientists and engineers at MIT. The new David H. Koch Institute, to be housed in the Koch Institute (completion date Dec 2010), will bring together in one building biologists, engineers and other scientists in order to stimulate interactive activities aimed at understanding, treating and curing human caners. While the building is not complete, the Koch Institute for Integrative Cancer Research has been established. Major area of research include the development of nanotechnology to specifically target caner cells, advanced imaging technology to improve the early detection of human caner, programming the immune system to recognize and attack cancer cells, and systems analysis of cancer pathways and drug resistance. These programs are combining MIT’s strengths in engineering and biology to develop the next generation of cancer treatments.

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments. If you don’t have an account yet, sign up now!

MIT Club of Northern California

MIT Club of Northern California

Category: Engineering | Updated 7 months ago

Created
April 19, 2011 13:27
Category
Tags
License
All Rights Reserved (What is this?)
Additional Files


Viewed
11273 times

More from MIT Club of Northern California

The MIT Logarhythms - MIT Club of Northern California

The MIT Logarhythms - MIT Club of N...

Added 7 months ago | 00:44:54 | 709 views

FAT Chance - Dr. Robert Lustig - MIT Club of Northern California

FAT Chance - Dr. Robert Lustig - MI...

Added over 1 year ago | 01:19:42 | 2428 views

Cancer Genetics and Precision Cancer Therapy - LSF - MIT Club of Northern California

Cancer Genetics and Precision Cance...

Added 1 year ago | 01:45:44 | 1434 views

Securing More Sustainable Solutions to Urban Water Challenges - Prof. Richard Luthy - MIT Club of Northern California

Securing More Sustainable Solutions...

Added 1 year ago | 01:08:24 | 1412 views

Unlock Your Social Media Potential - MIT Club of Northern California

Unlock Your Social Media Potential ...

Added over 2 years ago | 01:20:22 | 4455 views

Engineering Leadership - Prof. Joel Schindall - MIT Club of Northern California

Engineering Leadership - Prof. Joel...

Added 3 years ago | 00:47:58 | 17113 views